Trial NCT02805660

View at ClinicalTrials.gov 
Org. Study IDs: 0103-020

Last trial update was posted on 2021-04-06

MeSH Interventions

Durvalumab Mocetinostat

MeSH Conditions


Other Conditions

Advanced Cancer

Stopping Reasons

The study was discontinued early because the Sponsor de-prioritized development of mocetinostat. The decision to stop was not due to any patient safety issues.

Limitations And Caveats

The study was discontinued early because the Sponsor de-prioritized development of mocetinostat. The decision to stop was not due to any patient safety issues.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID